HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 129 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $239,000 | -43.0% | 11,950 | +1.5% | 0.00% | – |
| Q4 2021 | $419,000 | +76.8% | 11,777 | +79.9% | 0.00% | – |
| Q3 2021 | $237,000 | +8.7% | 6,545 | 0.0% | 0.00% | – |
| Q2 2021 | $218,000 | +16.6% | 6,545 | 0.0% | 0.00% | – |
| Q1 2021 | $187,000 | -20.8% | 6,545 | 0.0% | 0.00% | – |
| Q4 2020 | $236,000 | +5.8% | 6,545 | 0.0% | 0.00% | – |
| Q3 2020 | $223,000 | -91.2% | 6,545 | -92.4% | 0.00% | -100.0% |
| Q2 2020 | $2,526,000 | +94.0% | 85,904 | +18.3% | 0.00% | +100.0% |
| Q1 2020 | $1,302,000 | -44.6% | 72,645 | -22.5% | 0.00% | -50.0% |
| Q4 2019 | $2,349,000 | +52.8% | 93,711 | +8.8% | 0.00% | +100.0% |
| Q3 2019 | $1,537,000 | -3.3% | 86,156 | +19.3% | 0.00% | 0.0% |
| Q2 2019 | $1,589,000 | +1077.0% | 72,245 | +1541.9% | 0.00% | – |
| Q1 2019 | $135,000 | +32.4% | 4,400 | 0.0% | 0.00% | – |
| Q4 2018 | $102,000 | +142.9% | 4,400 | +238.5% | 0.00% | – |
| Q3 2018 | $42,000 | – | 1,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zeal Asset Management Ltd | 2,684,118 | $84,523,000 | 16.48% |
| Cederberg Capital Ltd | 3,400,000 | $108,868,000 | 2.00% |
| Capital International Sarl | 570,500 | $18,267,000 | 1.91% |
| AIA Group Ltd | 437,118 | $14,971,000 | 1.72% |
| Capital International, Inc./CA/ | 4,711,405 | $150,859,000 | 1.40% |
| M&G INVESTMENT MANAGEMENT LTD | 3,096,345 | $99,083,000 | 0.62% |
| Bellevue Group AG | 947,674 | $30,345,000 | 0.35% |
| Sands Capital Management | 7,051,916 | $225,802,000 | 0.22% |
| E Fund Management (Hong Kong) Co., Ltd. | 18,836 | $603,000 | 0.21% |
| Hudson Bay Capital Management LP | 1,031,212 | $33,020,000 | 0.18% |